Courts rule that prescribers don’t have to personally exam pt .. “virtual exam” is good enough ?

Telemedicine company wins order putting Texas remote treatment rule on hold

http://www.reuters.com/article/2015/06/01/health-texas-remote-idUSL1N0YN1C020150601

The TX medical board ruling is considered unreasonable restraint of trade under Sherman Antitrust… but.. drug wholesalers rationing controlled purchases to community pharmacy is NOT restraint of trade ?

Patients in Texas can continue to receive remote diagnoses and treatment after telemedicine company Teladoc Inc won a preliminary court order blocking a new state rule requiring doctors to meet patients first.

The ruling in Austin federal court on Friday came the same day that Teladoc filed its public registration with the U.S. Securities and Exchange Commission for an initial public offering. The company first announced its plans to go public in April.

Founded in 2002, Teladoc describes itself as one of the first and largest U.S. telemedicine services, with a network of about 700 doctors and 11 million patients nationwide. About 2.4 million patients are in Texas.

Telemedicine is the increasingly common practice of conducting diagnosis and treatment, including prescribing drugs, remotely using phones or interactive video.

In April the Texas Medical Board, which regulates the practice of medicine in the state, adopted a new rule requiring doctors to meet their patients face-to-face before prescribing drugs. The rule was to take effect this week.

Teladoc sued the board, claiming that the rule violated the federal Sherman Act, an antitrust law that prohibits unreasonable restraint of trade.

In Friday’s order, U.S. District Judge Robert Pitman said Teladoc had shown it was likely to succeed in its lawsuit. His order stops the rule from taking effect while the case is pending.

“We are happy to be able to continue serving Texas citizens, employers and health plans by enabling them to access high-quality care in a cost-effective manner,” Teladoc Chief Executive Officer Jason Gorevic said in a press release on Friday.

The Texas Medical board did not immediately respond to a request for comment.

The case is Teladoc Inc et al v. Texas Medical Board et al, U.S. District Court, Western District of Texas, No. 1:15-cv-00343. (Reporting by Brendan Pierson in New York; Editing by Ted Botha and Lisa Von Ahn)

 

Pt “not sick enough” to receive treatment.. must be on “death’s door” ?

Woman sues Anthem Blue Cross for denying hepatitis C drug Harvoni

http://www.dailynews.com/health/20150601/woman-sues-anthem-blue-cross-for-denying-hepatitis-c-drug-harvoni

The virus could win.

It wants to do to Shima Andre what it already has done to so many thousands of people worldwide: Drain her of energy. Change the color of her skin. Make her panic when she feels a pain on her right side.

But the 42-year-old West Hollywood woman with hepatitis C said there’s a sure-fire weapon on the market that could help her fight and kill the virus.

A drug called Harvoni is one of precious few prescription medications that can actually cure a virus. It’s been touted as a miracle drug. But her health insurer says she’s not sick enough and therefore the drug is not medically necessary. That’s why they won’t cover it.

Andre, who was diagnosed four years ago, is at an early stage of hepatitis C. She gets her viral load checked every six months. She endures ultrasounds on her liver. So far, the tumor that was discovered is benign, but the whites of her eyes are starting to change color. She wonders how much time she has.

She has filed a lawsuit against Anthem Blue Cross for denying Harvoni and for saying in a letter dated October of last year that until she has reached Stage 3 of severity, she can’t have the pills. That means that by the time Blue Cross approves the lifesaving drug for her, she will be too exhausted to work as a book editor, her liver will develop scar tissue and cirrhosis, and she may have to consider an organ transplant.

“I was shocked, devastated and outraged,” Andre said. “I thought it was a mistake.”

Denial letters for specialty drugs such as for those with diabetes, multiple sclerosis and HIV are becoming more common. The reason, say Andre’s attorneys and others: the cost. Harvoni’s price tag exceeds $90,000 for a 12-week prescription.

Andre’s attorneys say in the lawsuit that Blue Cross is obligated to help her obtain the drug and is violating state standards by ignoring her physician’s recommendations.

For Andre and many insured Americans with hepatitis C, Harvoni is the only way for her to fight the virus, not only for its high cure rate, but also because it has very few side effects. Harvoni, made by San Dimas-based Gilead Sciences, was approved by the U.S. Food and Drug Administration in 2014 and cures up to 99 percent of patients within 12 weeks.

Another drug, Sovaldi, was approved in late 2013 and is also billed as a cure, although it is not suited to all patients. It too is made by Gilead. There are no generic versions.

In the short time since the drugs have become available, physicians and their patients in California have already come up against dozens of denials.

In a little more than a year, there have been 135 independent medical review requests for both drugs to California’s Department of Managed Health Care, which regulates health plans. The requests seek appeals to decisions made by insurance plans and even HMOs. Of 135 reviews, the state overturned a health insurer’s denial 95 times.

“Imagine a health care company telling their patients with hepatitis C that they’re not sick enough yet to get a known cure,” said one of Andre’s attorneys, Ricardo Echeverria. “Blue Cross is simply putting profits over patients.”

Andre filed the lawsuit against Blue Cross in May, accusing them of withholding a cure for hepatitis C based on profits.

A spokesman with Anthem Blue Cross said the company could not comment on a pending lawsuit.

But Echeverria said his law firm has at least 10 more cases they’re looking at. And a lawsuit similar to Andre’s was filed recently on behalf of a man who has had hepatitis C for nearly 40 years. Blue Shield, his health plan, denied his physician’s prescription for Harvoni on the same basis: medical necessity.

He also said it would be less expensive to treat Andre than to wait until she is sicker. A study cited by the National Center for Biotechnology Information found that from 2007 to 2009, 19,907 patients were hospitalized in Los Angeles County due to hepatitis C. Their care cost $58 million, with more than 70 percent charged to government sources.

Meanwhile, it’s unclear how many reviews have been requested among some Medi-Cal managed-care recipients because those figures are not yet available, a spokesman with the Department of Health Care Service said. But among those who are on the Medi-Cal fee-for-service system, the department has received 1,489 treatment authorization requests from pharmacists since June 2014 for Harvoni and Sovaldi. Those requests are on behalf of 749 beneficiaries. Of these requests, 959 were denied by the state. A total of 71 appeals have been received; 12 of them were overturned and approved on appeal, while 53 were upheld and denied, and six are pending review.

The state’s hepatitis C treatment policy, released on July 1, 2014, “authorizes treatment for patients with documented Stage 3 or 4 (advanced hepatitis C), or treatment regardless of stage if the patient has appearances of hepatitis C outside the liver or has had a liver transplant,” among other criteria.

In January, Sovaldi and Harvoni were added to the Medi-Cal Contract Drug List.

“They are the preferred products to be considered when medically necessary for the treatment of a beneficiary who is infected with hepatitis C,” according to a response by the Department of Health Care Services.

While insurance denials for treatment for hepatitis C are receiving most of the current spotlight, physicians’ prescriptions for specialty drugs, even generic ones, are being denied more often, said Dr. Samuel Fink, a Tarzana-based internist who also is past president of the Los Angeles County Medical Association.

“In 2015 we’re witnessing a war among physicians and insurance companies,” Fink said. “I’ve had more denials this year than any year before. I don’t know if it’s Affordable Care Act related. The insurers are trying to control the care and treatment of patients.”

Though he hasn’t had to prescribe Harvoni, he said insurance companies are waiting out a patient’s illness, perhaps even until they sign on to another insurance plan.

“They’re just kicking the can down the road,” Fink said. “It’s extremely disheartening and discouraging, knowing that you can’t help your patient.”

Hepatitis C is a bloodborne infection that causes liver disease. It’s was discovered in 1990 and is usually spread person to person through needles and blood transfusions, among other ways. About 3.2 million people in the United States have chronic hepatitis C infection. According to the federal Centers for Disease Control and Prevention, it is an unrecognized health crisis. It is most prevalent among those born between 1945 and 1965, or the baby boomer generation, with a majority of them likely infected during the 1970s and 1980s when rates were highest, according to the CDC.

But most people don’t seek a cure because they don’t know they’re infected. That’s because most people with hepatitis C are asymptomatic but still may have chronic liver disease. It’s most commonly found when someone tries to donate blood.

The CDC recently urged all baby boomers be tested.

Because health plans have placed specialty drugs on different price tiers, those with chronic illnesses such as diabetes, HIV and even multiple sclerosis have had to pull out their own credit cards to pay hefty prices. That sparked a decision last month by Covered California to help reduce the monthly out-of-pocket costs for enrollees by spreading out the costs so that they don’t have to pay it all at once.

Those who purchased plans through the exchange will see their costs capped at an average of $250 per month per prescription. Overall, the caps will range from $150 to $500. The caps will begin later this year, but the move will be reviewed in 2016 to see if it has helped.

In addition, a proposed state bill, AB 339, mirrors Covered California’s change but would place limits on how much health plans can charge enrollees for outpatient prescriptions permanently. It would set a monthly cap of as little as $124.

As for Andre, she and her husband, Ted, would like to have a child, but she fears spreading the virus to her baby. Had she been given Harvoni last year when her physicians from Cedars-Sinai Medical Center prescribed it and even appealed for her, she would already be cured.

She said she has pursued a lawsuit to bring attention to what insurance plans are doing, but also because she is running out of time.

“This is a miracle drug,” Andre said. “There are thousands of folks going through this.”

Pharmacists may also have to be more critical of seemingly legitimate controlled substance prescriptions that could be harmful.

Allowing Drug Abusers to Sue Pharmacists Could Affect Opioid Dispensing

A West Virginia high court’s decision to allow drug abusers to sue pharmacists could have a far-reaching influence on controlled substance dispensing, the executive director of the state’s pharmacist association told Pharmacy Times.
 
The West Virginia Supreme Court of Appeals recently ruled that prescription drug abusers could sue the pharmacists who dispensed the drugs, on the basis that they caused or contributed to their addiction and subsequent criminal activities.
 
Some fear this court decision will create incentive for drug abusers to pursue damages claims against pharmacists. Even West Virginia Pharmacists Association executive director Richard Stevens told Pharmacy Times the ruling put pharmacists “in harm’s way.”
 
“Pharmacists can only protect themselves by exercising extreme caution in dispensing controlled substances—especially those products known to be abused—to individuals who are not patrons of their pharmacy” Stevens said.
 
To do so, pharmacists will need to pay close attention to the West Virginia Controlled Substances Monitoring Program, which contains information on all controlled substances dispensed—including the names of the prescriber and patient, quantities and names of products dispensed, and the names of the pharmacists dispensing them to the patient.
 
“[Pharmacists] will have to alert prescribing physicians if their patients are obtaining excessive quantities of controlled substances from other prescribers,” Stevens said. “This will certainly increase pharmacists’ workload.”
 
Pharmacists may also have to be more critical of seemingly legitimate controlled substance prescriptions that could be harmful.
 
According to the US Centers for Disease Control and Prevention, West Virginia’s painkiller prescribing rate ranks third in the country, and the state also has one of the highest opioid overdose death rates nationwide.

KC-area child porn investigation leads to DEA-issued computer

https://youtu.be/dm6xexu_wJY?t=3m32s

KC-area child porn investigation leads to DEA-issued computer

http://www.kansascity.com/news/local/crime/article22867965.html

An Overland Park detective’s child pornography investigation led to an unexpected place — a local office of the federal Drug Enforcement Agency.

And evidence found on a laptop computer at the DEA office in Overland Park led to an analyst for a regional drug interdiction program, who pleaded guilty Monday in U.S. District Court.

The case against 34-year-old Matthew J. Barnes, who is scheduled to be sentenced in August, began in March 2012 when the detective assigned to the FBI Cyber Crimes Task Force used peer-to-peer file-sharing software to look for online child porn.

According to the plea agreement filed in federal court, the detective’s computer found another computer that shared six images of child pornography and “child erotica.”

The detective learned that the computer’s IP address was assigned to the DEA office.

After the detective and two FBI agents went to the office, DEA officials helped determined that the computer was assigned to Barnes, according to the plea agreement.

According to the document, Barnes was a member of the Missouri National Guard working as an analyst for the Midwest High-Intensity Drug Trafficking Areas program, or HIDTA.

Midwest HIDTA coordinates local, state and federal drug enforcement efforts in a six-state area that includes Kansas and Missouri.

After obtaining the password for Barnes’ computer, investigators found that a file-sharing program was operating and displayed images of child pornography. A thumb drive attached to the computer contained child pornography images, according to the plea agreement.

Barnes waived his right to a grand jury indictment and pleaded guilty to one count of possession of child pornography. The charge carries a potential sentence of up to 10 years in prison.

To reach Tony Rizzo, call 816-234-4435 or send email to trizzo@kcstar.com

You think that Rx meds are expensive now ?

U.S. Supreme Court Lets Alameda County Make Big Pharma Pay for Drug Disposal

http://www.allgov.com/usa/ca/news/where-is-the-money-going/us-supreme-court-lets-alameda-county-make-big-pharma-pay-for-drug-disposal-150602?news=856623

Who should pay for rounding up soon-to-be-discarded prescription drugs before they wind up poisoning the environment? Taxpayers or pharmaceutical companies?

In July 2012, the Alameda County Board of Supervisors voted unanimously that Big Pharma should set up a program to get rid of expired and otherwise unwanted drugs, and were promptly taken to court by the Pharmaceutical Research and Manufacturers of America, the Generic Pharmaceutical Association and the Biotechnology Industry Organization.

The drug manufacturers lost (pdf) in U.S. District Court and the U.S. Ninth Circuit Court of Appeals. Last week, the U.S. Supreme Court refused to hear their appeal, opening the door to other jurisdictions to follow suit.

Alameda is the first county in the nation to make drug manufacturers pay at least a part of the cost of encouraging people to do the right thing and giving them a means to do it. That means setting up collection points, publicizing the locations and disposing of the drugs.

At the time of the lawsuit, the county sheriff’s office maintained 28 drug drop-off boxes for abandoned drugs. The Alameda law is based on a program started 18 years ago in British Columbia, Canada, which allows consumers to turn in drugs at pharmacies for no charge. A study in 2009 found that the volume of drugs turned in went steadily up and participation by pharmacies was very high.    

It was estimated that the industry would be on the hook for about $330,000 a year in the county.

The plaintiffs in the case dispute that such programs change human behavior. But the core of their legal argument was that the law violates the U.S. Constitution’s Interstate Commerce Clause by interfering with the free flow of goods by out-of-state drug manufacturers.

The Ninth Circuit Court recognized that the ordinance would cost the companies money, but noted, “Significantly, Plaintiffs provide no evidence that the Ordinance will interrupt, or even decrease, the ‘flow of goods’ into or out of Alameda.”

But Judge N. Randy Smith, writing wrote for the court, emphasized that it wasn’t ruling on the wisdom of the law: “Opinions vary widely as to whether adoption of the Ordinance was a good idea. We leave that debate to other institutions and the public at large.”

For some, that debate has already been held and they are ready to move. San Francisco passed a similar ordinance in January and has been waiting to see the outcome of the case to implement it. San Mateo County is ready to go and Santa Clara County is considering one, according to the San Francisco Chronicle.

Alameda County now joins Canada, Mexico and much of South America in asking a manufacturer to help clean up the environmental mess made by their product as part of the cost of doing business. It is not a widely-applied concept.

A QUANTUM LEAP in the right direction – a bit naive ?

Today is the beginning of the Gloucester Initiative. Our doors are open and will remain so until every addict who seeks help with their disease has treatment. I want to reiterate that every addict who walks into the Gloucester Police Department intent on seeking help will not be charged, We will fast track you to treatment. You will receive no judgment; just professionalism, respect and compassion. Narcan is now available at Conleys, CVS, and Walgreens in Gloucester. We will pay for those who do not have insurance. And we will pay for family members of addicts who do not have insurance so that no one will have to watch a loved one die for lack of money to pay for a medication that could have saved them. We will continue to push for legislation so that seized monies can be earmarked for addiction and recovery at a state and federal level. We will continue to speak with legislators, insurance companies and pharmaceuticals so that addiction is treated as a DISEASE.

And as the national conversation starts to swing toward realization that addiction is a disease, please watch for further developments here, including PAARI, which we hope to unveil within two weeks. We believe it to be a game changer in the national epidemic of opiate abuse.

If you are an addict or a loved one of an addict, that’s our promise to you. All you have to do is take advantage, when you’re ready, to get your life back. We believe you can. We’ll be here.

Chief Campanello

Out of sync priorities ?

Under pressure: Performance metrics in chains may affect safety

https://www.pharmacist.com/under-pressure-performance-metrics-chains-may-affect-safety

out of sync of priorities ? as a pt… your health is everything to you… the Pharmacist cares only about their license/job and paycheck ? and those in the E-suite of the corporate chain pharmacies… it is all about profits and stock price. Medication errors – that can harm pts –  are just the cost of doing business. Because healthcare is now JUST A BUSINESS ?

pressure that many chain pharmacists feel

“It’s all about numbers. That’s all they care about. You’re there and on your feet for 8 hours, and you’re at the mercy of the volume.”


The speaker was Bill Bradshaw, BSPharm, a semiretired former Walgreens pharmacist from Arlington, TX. He was describing the pressure that many chain pharmacists feel as they try to meet prescription fill-time goals while fielding phone calls, managing auxiliary staff, and keeping up with immunizations and customers’ medication therapy needs. 


The yardsticks companies use to evaluate how well pharmacists manage these complex professional duties are known collectively as “performance metrics.” It is a phrase that pops up frequently in pharmacists’ blogs, tweets and other online forums—and not usually in a positive way. A common thread is that use of metrics to help speed prescription flow often runs counter to good pharmacy practice and heightens the danger of increased medication error rates.


“It’s time pharmacists are protected from this metrics system,” wrote Katrin Olavessen-Holt, commenting on a Pharmacy Today Facebook posting of a March 3, 2015, CBS Sacramento article headlined “Call Kurtis: Pharmacists Concerned Employer Pressure Leads to Prescription Errors.”


“Speed and money over safety. Never a good thing!!,” added Carrie Wellman Arbuckle. The article describes the potential downside of performance metrics in California. The Today posting drew more than 325 “likes” from Facebook followers.


Major chains: Different view


The three major pharmacy chains have a different view of the metrics they use to evaluate pharmacy performance. And they cite their efforts to smooth pharmacy workflow and ensure customer satisfaction and safety. 


CVS/pharmacy spokesman Michael DeAngelis responded to Today ’s request for comment with a statement saying that CVS, like other companies, “measures the quality and effectiveness of the services we provide to ensure we are meeting our customers’ expectations and helping them to achieve the best possible outcomes. Our systems are designed to help our pharmacists manage and prioritize their work to best serve their patients.”


Jim Cohn, a Walgreens spokesman, said in an e-mail that “quality, safety, and accuracy are our top priorities, and we make it clear to our pharmacists that they should never work beyond what they believe is safe, in their professional judgment.”


At Rite Aid, spokeswoman Ashley Flower stated that the chain was “highly committed to patient safety and care,” adding, “We have a strong safety record because of our ongoing education and training for pharmacy associates as well as our continued investment in technology.” Rite Aid, she said, uses “various metrics to ensure we are consistently delivering a superior customer experience and helping those we serve achieve the best possible health outcomes.”


The safety equation


While the chains do invest heavily in new technology systems, workflow design and training programs to meet the expanding demands on pharmacists’ time, there is always the risk that ever-increasing prescription volume and bottom-line considerations may tilt the safety equation to the negative side. Moreover, policies created at the top to ensure that pharmacists are well equipped to handle both dispensing and patient care responsibilities can encounter obstacles as they filter down to supervisors, who themselves may be under pressure to perform. 


David Nau, BSPharm, MS, PhD, president of Pharmacy Quality Solutions Inc., noted that many studies in the past had shown an association between volume of work and medication error rates. “One thing that makes a difference,” he said, “is that the complexity of work, or the workload issue, is intertwined with staffing and processes. Part of the issue of reducing distractions of pharmacists is finding the right balance of workload and the pace of work.”


Some pharmacists maintain, however, that the balance can be thrown off kilter by technician staffing that fails to account for the high number of prescriptions that pharmacies are called on to dispense. “They keep cutting tech staff hours, regardless of the volume,” said Steve Ariens, BSPharm, national public relations director for the Pharmacy Alliance, a pharmacists’ advocacy group. He likened it to the slave galley rowing scene in the 1959 movie classic Ben-Hur. “Rowing faster and faster: that’s pharmacy,” he said.


Bill Bradshaw said it was “practically impossible to do your job the way it was supposed to be done with the help that they gave you.” At one Fort Worth, TX, Walgreens where he worked, “it was very intense,” he said. A doctor he consulted told him that he was suffering from post-traumatic stress disorder. He finally left the pharmacy after about 3.5 years. During that time, he said, “That one store had five pharmacy managers. They just couldn’t handle it.”


‘From green to yellow to red’


One widely used performance metric tracks prescription dispensing time from customer drop-off to pick-up bin. The limit is often set at 15 minutes. David Stanley, BSPharm, a California pharmacist who worked for both Rite Aid and Walgreens, told Today that both chains used computer clocks to monitor the time. The clocks “would slowly turn from green to yellow to red,” he said, “depending on how quickly prescriptions were getting out the door.” 


Stanley added that he saw “nothing wrong” with metrics in general, particularly if used to evaluate quality, but “the problem I’ve run into is that they choose their metrics poorly. And they lose sight of the goal, which is happy customers and pharmacy practice the way it is supposed to be practiced.”


He described a prescription label policy that Rite Aid had in effect when he worked there several years ago. “We were told never to print more than five labels ahead,” he said, but “we had our own way of doing things, which was to print labels for as many prescriptions as we could and get them as close to being filled as we could. That way, when it was slow, you could work on the label pile and basically get a few out the door in between customers. It was a great system,” he said. “When we started following their directive, it actually slowed us down and it worked against their larger goal of happy customers and quality prescriptions.”


“They didn’t want to hear it,” he said.


Lawsuits against chains


Some pharmacists have brought lawsuits against chains. Joseph Zorek, BSPharm, for instance, has a current suit against CVS Health. He told Today that performance policies and “intimidation” he encountered as pharmacist-in-charge at a Harrisburg, PA, CVS pharmacy, led to various physical ailments and disability—the basis for his legal action.


Zorek described one metric CVS used to evaluate performance. “They wanted us to sign up all patients to ReadyFill,” the chain’s automatic prescription-filling program. He said his patient base consisted of a higher-than-average number of senior citizens, who “felt much more comfortable being in charge of their own prescriptions. As a result, my metric for signing up people was low.”


Zorek added that he felt he could “play ball” with most of the other requirements. “They had a 15-minute constraint” for measuring prescription fulfillment time. “That was fine,” he said, “but normally Murphy’s Law would set in, and something would go wrong.” Describing a hectic pharmacy scene in which techs were often called away to take over busy cash registers and pharmacists were forced to handle calls on 10 different telephone lines, he said, “Your mind was in too many places. The error rate started to go up. We were making stupid little mistakes: using the son instead of the father, wrong address, improper doctor. ”


Still, Zorek said, he “enjoyed the pace and working with people”—that is, until the company began cutting technician hours. His wife, Paula Zorek, who also worked at CVS, as a technician and technician trainer, said that in 2011, every store was losing technician hours. “They upgraded the computer software,” she said, “and they thought they could do more with less. It didn’t work out that way.”


2012 ISMP/APhA survey


Anecdotal complaints about the use of metrics and pharmacy workload have circulated for years. In 2012, the Institute for Safe Medication Practices (ISMP) launched a survey in collaboration with APhA. One aim was to assess the impact of prescription fill-time guarantees on pharmacy safety. A total of 673 pharmacists responded, most of them from chain drug and grocery/mass merchant pharmacies. A major finding was that 83% of those working at pharmacies with advertised time guarantees believed that the guarantees were contributing to dispensing errors. 


In response, the National Association of Boards of Pharmacy (NABP) issued a statement resolving that NABP “assist the state boards of pharmacy to regulate, restrict, or prohibit the use in pharmacies of performance metrics or quotas that are proven to cause distractions and unsafe environments for pharmacists and technicians.” 


Fewer errors: One solution


Are there solutions for reducing the potential safety hazards of performance metrics and prescription time-filling guarantees? Nau, whose company supports health plans, PBMs, and community pharmacies in their efforts to measure and improve medication use quality through its EQuIPP program, said that “we actually find that when pharmacies synchronize the refills of patients on chronic medications, it helps to smooth out the workflow and balance the ebb and flow of volume throughout the day.”


That should help lead to fewer errors, he noted. He also said that as “pharmacists do more to be proactively engaged in managing their patients’ regimens, it will help to balance the workload. So when issues arise, that communication will help to identify potential issues before they become a major event for the patient.” 


 

I bet pharmacy will get blamed for all of these control meds getting on the street

Riot Pharmacy Looting Linked To Spike In City Crime

http://baltimore.cbslocal.com/2015/06/01/riot-pharmacy-looting-linked-to-spike-in-city-crime/

BALTIMORE (WJZ) — City leaders are connecting the spike in violence to the theft of thousands of dollars worth of prescription drugs from local pharmacies during the April 27th riots.

Derek Valcourt spoke with frustrated pharmacy owners who say police aren’t doing enough to help.

The CVS — just one of the many stores – looted that day.

Some worry the drugs that were taken may now be fueling violent territory disputes.

 Meanwhile, pharmacy owners WJZ talks to say police aren’t doing enough to investigate who stole those drugs to begin with.

Inside the Care One Pharmacy on Reisterstown Road surveillance cameras are watching all as they were on April 27th — when looters entered the locally-owned pharmacy and began wreaking havoc.

Manager Ora Powers showed WJZ security video that details minute by minute what happened inside the pharmacy.

The thieves — many with their faces covered stole thousands of pills and can be seen trying to break open the buildings safe with a crow bar.

When that didn’t work, they carried an ATM machines right out of the lobby.

“It’s frightening,” Powers said.

Some of the first damage inside this pharmacy happened between 3 and 4 in the afternoon, looters were in this building almost all night long taking whatever they could get their hands on.

By 1 a.m., most shelves were stripped bare — and they weren’t alone.

Looters caused damage to more than two dozen local pharmacies, including the now closed CVS store, the Keystone Pharmacy on North Avenue and another Care One store on Pennsylvania Avenue.

Derek: “Did the police come right away?”

Powers: “No, they actually never came.”

Care One’s owners tell WJZ despite reporting the burglary in progress, a police detective didn’t come until a few days ago — more than a month after that break-in.

They say detectives still don’t have a copy of security video.

Meanwhile employees are still putting the place back together.

“Pretty much trying to recover from this. We’re still a little off as you can see we haven’t replaces some things yet. It’s costly,” Powers said.

In a statement, police say they are committed to investigating each and every one of these pharmacy crimes — and say their investigations into pharmacy thefts have already resulted in 8 arrests and 8 outstanding warrants.

The DEA is also involved in some of the investigations.

Anyone with information on these crimes is urged to call Baltimore police.

Ken Mc Kim and Gastroparesis

 

driving away 40 years of irreplaceable clinical experience ?

Move to Electronic Records Has Pushed Doctors Out

About a decade ago, a doctor friend was lamenting the increasingly frustrating conditions of clinical practice. “How did you know to get out of medicine in 1978?” he asked with a smile.

“I didn’t,” I replied. “I had no idea what was coming. I just felt I’d chosen the wrong vocation.”

I was reminded of this exchange upon receiving my med-school class’s 40th-reunion report and reading some of the entries. In general, my classmates felt fulfilled by family, friends and the considerable achievements of their professional lives. But there was an undercurrent of deep disappointment, almost demoralization, with what medical practice had become.

The complaint was not financial but vocational — an incessant interference with their work, a deep erosion of their autonomy and authority, a transformation from physician to “provider.”
As one of them wrote, “My colleagues who have already left practice all say they still love patient care, being a doctor. They just couldn’t stand everything else.” By which he meant “a never-ending attack on the profession from government, insurance companies, and lawyers . . . progressively intrusive and usually unproductive rules and regulations,” topped by an electronic health records (EHR) mandate that produces nothing more than “billing and legal documents” — and degraded medicine.

I hear this everywhere. Virtually every doctor and doctors’ group I speak to cites the same litany, with particular bitterness about the EHR mandate. As another classmate wrote, “The introduction of the electronic medical record into our office has created so much more need for documentation that I can only see about three-quarters of the patients I could before, and has prompted me to seriously consider leaving for the first time.”

You may have zero sympathy for doctors, but think about the extraordinary loss to society — and maybe to you, one day — of driving away 40 years of irreplaceable clinical experience.

And for what? The newly elected Barack Obama told the nation in 2009 that “it just won’t save billions of dollars” — $77 billion a year, promised the administration — “and thousands of jobs, it will save lives.” He then threw a cool $27 billion at going paperless by 2015.

It’s 2015 and what have we achieved? The $27 billion is gone, of course. The $77 billion in savings became a joke. Indeed, reported the Health and Human Services inspector general in 2014, “EHR technology can make it easier to commit fraud,” as in Medicare fraud, the copy-and-paste function allowing the instant filling of vast data fields, facilitating billing inflation.

That’s just the beginning of the losses. Consider the myriad small practices that, facing ruinous transition costs in equipment, software, training and time, have closed shop, gone bankrupt or been swallowed by some larger entity.

This hardly stays the long arm of the healthcare police, however. As of Jan. 1, 2015, if you haven’t gone electronic, your Medicare payments will be cut, by 1 percent this year, rising to 3 percent (potentially 5 percent) in subsequent years.

Then there is the toll on doctors’ time and patient care. One study in the American Journal of Emergency Medicine found that emergency-room doctors spend 43 percent of their time entering electronic records information, 28 percent with patients. Another study found that family-practice physicians spend on average 48 minutes a day just entering clinical data.

Forget the numbers. Think just of your own doctor’s visits, of how much less listening, examining, even eye contact goes on, given the need for scrolling, clicking and box checking.

The geniuses who rammed this through undoubtedly thought they were rationalizing healthcare. After all, banking went electronic. Why not medicine?

Because banks deal with nothing but data. They don’t listen to your heart or examine your groin. Clicking boxes on an endless electronic form turns the patient into a data machine and cancels out the subtlety of a doctor’s unique feel and judgment.

Why did all this happen? Because liberals in a hurry refuse to trust the self-interested wisdom of individual practictioners, who were already adopting EHR on their own, but gradually, organically, as the technology became ripe and the costs tolerable. Instead, Washington picked a date out of a hat and decreed: Digital by 20Move to Electronic Records Has Pushed Doctors Out15.

The results are not pretty. EHR is healthcare’s Solyndra. Many, no doubt, feasted nicely on the $27 billion, but the rest is waste: money squandered, patient care degraded, good physicians demoralized.

Like my old classmates who signed up for patient care — which they still love — and now do data entry.

Charles Krauthammer is a Pulitzer Prize-winning syndicated columnist, published weekly in more than 400 newspapers worldwide. From 2001 to 2006, he served on the president’s Council on Bioethics. He is author of the New York Times best-seller “Things That Matter: Three Decades of Passions, Pastimes and Politics.” For more of Charles Krauthammer’s reports, Go Here Now.

Read Latest Breaking News from Newsmax.com http://www.newsmax.com/CharlesKrauthammer/Healthcare-EHR-Obama/2015/05/29/id/647489/#ixzz3bkkx3DvZ
Urgent: Rate Obama on His Job Performance. Vote Here Now!